CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,230,845
- in 7 filings, $1.6M under 10b5-1 plans
Net −$2,230,845. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-07 | Patel Anish CHIEF OPERATING OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −10,700 | 67 | ||
| 2025-01-07 | Patel Anish CHIEF OPERATING OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −2,000 | 827 | ||
| 2025-01-07 | Patel Anish CHIEF OPERATING OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −9,000 | 44,342 | ||
| 2025-01-03 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +1,000 | $2.48 | $2K | 14,000 |
| 2025-01-03 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,000 | $25.04 | $25K | 13,000 |
| 2025-01-03 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −1,000 | 150,306 | ||
| 2024-12-30 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +900 | $2.48 | $2K | 900 |
| 2024-12-30 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −900 | $22.51 | $20K | 0 |
| 2024-12-30 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −900 | 164,306 | ||
| 2024-12-27 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +3,350 | $2.48 | $8K | 3,350 |
| 2024-12-27 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −3,350 | $22.15 | $74K | 0 |
| 2024-12-27 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −3,350 | 165,206 | ||
| 2024-12-13 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +13,000 | $2.48 | $32K | 13,000 |
| 2024-12-13 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −13,000 | 155,556 | ||
| 2024-11-27 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +5,250 | $2.48 | $13K | 5,250 |
| 2024-11-27 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −4,250 | $24.78 | $105K | 1,000 |
| 2024-11-27 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,000 | $25.38 | $25K | 0 |
| 2024-11-27 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −5,250 | 168,556 | ||
| 2024-10-28 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +6,250 | $2.48 | $16K | 6,250 |
| 2024-10-28 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −5,600 | $28.49 | $160K | 650 |
Page 14 of 37 · 724 trades